2025-04-08 17:33:10
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Glenmark Pharmaceuticals Ltd Q4 FY2022 consolidated PAT lower at Rs. 155.58 crores
Posted On : 2022-05-29 16:39:35( TIMEZONE : IST )
Glenmark Pharmaceuticals Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 3126.349 crores during the period ended March 31, 2022 as compared to Rs. 3187.309 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 155.587 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 221.902 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 5.51 for the period ended March 31, 2022 as compared to Rs. 7.86 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹3126.349 crs | ₹3187.309 crs |  -1.91% |
| Net Profit | ₹155.587 crs | ₹221.902 crs | -29.88% |
| EPS | ₹5.51 | ₹7.86 | -29.90% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs.3126.349 crores during the period ended March 31, 2022 as compared to Rs.2868.392 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.155.587 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.233.993 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.5.51 for the period ended March 31, 2022 as compared to Rs.8.29 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹3126.349 crs | ₹2868.392 crs |  8.99% |
| Net Profit | ₹155.587 crs | ₹233.993 crs | -33.51% |
| EPS | ₹5.51 | ₹8.29 | -33.53% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.12471.577 crores during the Financial Year ended March 31, 2022 as compared to Rs.10994.145 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.941.711 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.970.038 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.33.37 for the Financial Year ended March 31, 2022 as compared to Rs.34.38 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹12471.577 crs | ₹10994.145 crs | 13.44% |
| Net Profit | ₹941.711 crs | ₹970.038 crs | -2.92% |
| EPS | ₹33.37 | ₹34.38 | -2.94% |
Shares of Glenmark Pharmaceuticals Limited was last trading in BSE at Rs. 398.05 as compared to the previous close of Rs. 393.60. The total number of shares traded during the day was 131445 in over 2464 trades.
The stock hit an intraday high of Rs. 402.45 and intraday low of 391.90. The net turnover during the day was Rs. 52051203.00.
